Paper7831442
Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function.
Palfreyman MG and 7 others. Psychopharmacology (Berl), 1993. Cited by 108 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function. Papers, record 7831442. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7831442
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Behavior, Animal | Major topic |
| Dopamine | Major topic |
| Receptors, Serotonin | Major topic |
| Animals | |
| Basal Ganglia Diseases | |
| Electrophysiology | |
| Fluorobenzenes | |
| Indoles | |
| Male | |
| Mice | |
| Microdialysis | |
| Motor Activity | |
| N-Methyl-3,4-methylenedioxyamphetamine | |
| Neurons | |
| Piperidines | |
| Quinolizines | |
| Rats | |
| Rats, Sprague-Dawley | |
| Serotonin Antagonists |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,686,766 | L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats. | Eur J Pharmacol | 1991 | https://conductscience.org/library/papers/1686766 | PubMed |
| 2 | 37,098 | Binding characteristics of 3H-prazosin to rat brain alpha-adrenergic receptors. | Eur J Pharmacol | 1979 | https://conductscience.org/library/papers/37098 | PubMed |
| 3 | 808,430 | Biochemical indentification of the mammalian muscarinic cholinergic receptor. | Fed Proc | 1975 | https://conductscience.org/library/papers/808430 | PubMed |
| 4 | 1,899,117 | 5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa. | J Pharmacol Exp Ther | 1991 | https://conductscience.org/library/papers/1899117 | PubMed |
| 5 | 308,384 | Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites. | Brain Res | 1978 | https://conductscience.org/library/papers/308384 | PubMed |
| 6 | 3,696,238 | Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. | Nature | 1987 | https://conductscience.org/library/papers/3696238 | PubMed |
| 7 | 2,682,729 | Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. | Psychopharmacology (Berl) | 1989 | https://conductscience.org/library/papers/2682729 | PubMed |
| 8 | 6,225,026 | Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. | Nature | 1983 | https://conductscience.org/library/papers/6225026 | PubMed |
| 9 | 1,974,858 | Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine. | Eur J Pharmacol | 1990 | https://conductscience.org/library/papers/1974858 | PubMed |
| 10 | 4,200,724 | Strychnine binding associated with glycine receptors of the central nervous system. | Proc Natl Acad Sci U S A | 1973 | https://conductscience.org/library/papers/4200724 | PubMed |
| 11 | 2,433,425 | Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. | J Pharmacol Exp Ther | 1987 | https://conductscience.org/library/papers/2433425 | PubMed |
| 12 | 953,733 | Evidence for the existence of a raphe projection to the substantia nigra in rat. | Brain Res | 1976 | https://conductscience.org/library/papers/953733 | PubMed |
| 13 | 2,892,580 | Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons. | Brain Res | 1987 | https://conductscience.org/library/papers/2892580 | PubMed |
| 14 | 6,291,953 | [3H]Rauwolscine and [3H]yohimbine binding to rat cerebral and human platelet membranes: possible heterogeneity of alpha 2-adrenoceptors. | Eur J Pharmacol | 1982 | https://conductscience.org/library/papers/6291953 | PubMed |
| 15 | 4,202,581 | Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. | Biochem Pharmacol | 1973 | https://conductscience.org/library/papers/4202581 | PubMed |
| 16 | 7,099,138 | [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. | Mol Pharmacol | 1982 | https://conductscience.org/library/papers/7099138 | PubMed |
| 17 | 4,052,777 | Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. | Brain Res | 1985 | https://conductscience.org/library/papers/4052777 | PubMed |
| 18 | 648,590 | Histamine H1-receptors in brain labeled with 3H-mepyramine. | Eur J Pharmacol | 1978 | https://conductscience.org/library/papers/648590 | PubMed |
| 19 | 7,452,238 | Na+-independent binding of [3H]GABA and [3H]muscimol to subcellular particles of neural primary cultures and whole brain. | J Neurochem | 1980 | https://conductscience.org/library/papers/7452238 | PubMed |
| 20 | 1,425,989 | The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine. | Eur J Pharmacol | 1992 | https://conductscience.org/library/papers/1425989 | PubMed |
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 108 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37,886,127 | μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37886127 | PubMed |
| 35,381,208 | "Selective" serotonin 5-HT2A receptor antagonists. | Biochem Pharmacol | 2022 | https://conductscience.org/library/papers/35381208 | PubMed |
| 33,370,241 | International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function. | Pharmacol Rev | 2021 | https://conductscience.org/library/papers/33370241 | PubMed |
| 32,095,916 | Effects of combined 5-HT2A and cannabinoid receptor modulation on a schizophrenia-related prepulse inhibition deficit in mice. | Psychopharmacology (Berl) | 2020 | https://conductscience.org/library/papers/32095916 | PubMed |
| 29,532,180 | Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action. | Handb Exp Pharmacol | 2018 | https://conductscience.org/library/papers/29532180 | PubMed |
| 27,671,323 | The antidepressant bupropion is a negative allosteric modulator of serotonin type 3A receptors. | Neuropharmacology | 2017 | https://conductscience.org/library/papers/27671323 | PubMed |
| 26,456,305 | Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD). | Drug Test Anal | 2016 | https://conductscience.org/library/papers/26456305 | PubMed |
| 26,088,184 | Neural and behavioural changes in male periadolescent mice after prolonged nicotine-MDMA treatment. | Metab Brain Dis | 2016 | https://conductscience.org/library/papers/26088184 | PubMed |
| 24,403,876 | MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology. | Curr Neuropharmacol | 2013 | https://conductscience.org/library/papers/24403876 | PubMed |
| 24,321,440 | Effects of 5-hydroxytryptamine 2C receptor agonist MK212 and 2A receptor antagonist MDL100907 on maternal behavior in postpartum female rats. | Pharmacol Biochem Behav | 2014 | https://conductscience.org/library/papers/24321440 | PubMed |
| 24,232,860 | The role of different serotonin receptor subtypes in seizure susceptibility. | Exp Brain Res | 2014 | https://conductscience.org/library/papers/24232860 | PubMed |
| 22,056,993 | 5-HT2A receptor antagonist M100907 reduces serotonin synthesis: an autoradiographic study. | Brain Res Bull | 2012 | https://conductscience.org/library/papers/22056993 | PubMed |
| 21,782,029 | Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone. | Neuroimage | 2012 | https://conductscience.org/library/papers/21782029 | PubMed |
| 21,159,151 | Treatment of the psychostimulant-sensitized animal model of schizophrenia. | CNS Neurosci Ther | 2011 | https://conductscience.org/library/papers/21159151 | PubMed |
| 20,627,663 | The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats. | Eur Neuropsychopharmacol | 2010 | https://conductscience.org/library/papers/20627663 | PubMed |
| 20,111,859 | Antagonism at serotonin 5-HT(2A) receptors modulates functional activity of frontohippocampal circuit. | Psychopharmacology (Berl) | 2010 | https://conductscience.org/library/papers/20111859 | PubMed |
| 19,430,578 | Hypothesis-driven medication discovery for the treatment of psychostimulant addiction. | Curr Drug Abuse Rev | 2008 | https://conductscience.org/library/papers/19430578 | PubMed |
| 19,128,203 | The role of 5-HT3 receptors in drug abuse and as a target for pharmacotherapy. | CNS Neurol Disord Drug Targets | 2008 | https://conductscience.org/library/papers/19128203 | PubMed |
| 18,615,139 | Modulation of midbrain dopamine neurotransmission by serotonin, a versatile interaction between neurotransmitters and significance for antipsychotic drug action. | Curr Neuropharmacol | 2006 | https://conductscience.org/library/papers/18615139 | PubMed |
| 17,049,611 | Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. | Pharmacol Ther | 2007 | https://conductscience.org/library/papers/17049611 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HTR3A | 3,359 | PubTator's text mining | https://conductscience.org/library/genes/3359 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7831442
GET https://conductscience.org/api/papers/v1/7831442/references?page=2